关键词：结肠直肠癌；癌症；遗传性疾病；炎症性肠疾病；生物制品；辐射疗法
摘 要：Colorectal cancer is a type of cancer that affects the colon or rectum. It is mainly due to abnormal growth of cells that can be metastasized into other parts of the body. The formation of adenocarcinomas is the common feature of colorectal cancer. An adenocarcinoma starts as a benign or malignant polyp in the innermost wall of the colon or the rectum. The risk factors for this cancer include age, family history, unhealthy lifestyle, genetic disorders, and inflammatory bowel disease. Some of the symptoms of cancer include rectal bleeding, constipation, decreased appetite, nausea, bloating, significant or unexplained weight loss and pelvic pain. To alleviate this disease, chemotherapy, surgical, biologic, and radiation therapies are being developed and administered to colorectal patients.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

Vectibix

PART 03: Product profiles

Stivarga

Erbitux

Xeloda

Avastin

Zaltrap

PART 04: Market research methodology

Research methodology

Economic indicators

PART 05: Introduction

Key market highlights

PART 06: Disease overview

Understanding the disease

High risk factors

Signs and symptoms

Pathophysiology

Diagnosis

Staging

Biomarker testing

Epidemiology

Treatment

PART 07: Pipeline portfolio

Information on pipeline candidates

PART 08: Market landscape

Market overview

Market size and forecast

Colorectal cancer therapeutics market in Japan

Colorectal cancer therapeutics market in China

Five forces analysis

PART 09: Market segmentation by based on the type of

molecules

Small molecules

Biologics

PART 10: Market segmentation by route of

administration

Oral

Parenteral

PART 11: Market segmentation by lines of chemotherapy

First-line chemotherapy

Second-line chemotherapy

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

Competitive scenario

Market share analysis 2014

Other prominent vendors

Amgen

PART 18: Key vendor analysis

Bayer HealthCare

Bristol-Myers Squibb

Chugai Pharmaceutical

Merck

Sanofi

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio